HIPPOCAMPAL OVERACTIVITY

Clinical trials for HIPPOCAMPAL OVERACTIVITY explained in plain language.

Never miss a new study

Get alerted when new HIPPOCAMPAL OVERACTIVITY trials appear

Sign up with your email to follow new studies for HIPPOCAMPAL OVERACTIVITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Can a low-dose seizure drug protect aging brains? new study aims to find out.

Symptom relief Recruiting now

This study tests whether a low-dose, slow-release drug called AGB101 can reduce overactivity in a key memory region of the brain in healthy older adults. Over 60 participants aged 50-80 will receive both the drug and a placebo in random order, each for two weeks. The main goal is…

Matched conditions: HIPPOCAMPAL OVERACTIVITY

Phase: PHASE2 • Sponsor: Johns Hopkins University • Aim: Symptom relief

Last updated Apr 26, 2026 20:00 UTC

HIPPOCAMPAL OVERACTIVITY

Get alerted when new HIPPOCAMPAL OVERACTIVITY trials appear

Can a low-dose seizure drug protect aging brains? new study aims to find out.